Review | Open Access

Monoclonal gammopathies and their management in Gaucher disease type 1

 

Views:  17
Rare Dis Orphan Drugs J 2025;4:[Accepted].
Author Information
Article Notes
Cite This Article

Abstract

Gaucher disease type 1 (GD1) is a rare autosomal recessive genetic disorder characterized by deficiency of the lysosomal enzyme glucocerebrosidase. Among the various clinical manifestations that have been well described for decades, a more recent finding has been the association of GD1 with increased risk of various malignancies, including the monoclonal gammopathy multiple myeloma. We present a brief review describing the relationship between GD1 and monoclonal gammopathies, as well as the modern standard in the monitoring and management of these conditions.

 

 

Keywords

Rare disease, Gaucher, multiple myeloma, monoclonal gammopathy

Cite This Article

Lorber J, Rosenbloom BE. Monoclonal gammopathies and their management in Gaucher disease type 1. Rare Dis Orphan Drugs J 2025;4:[Accept]. http://dx.doi.org/10.20517/rdodj.2025.30

Copyright

...
© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Cite This Article 1 clicks
Share This Article
Scan the QR code for reading!
See Updates
Hot Topics
rare disease | orphan drug |
Rare Disease and Orphan Drugs Journal
ISSN 2771-2893 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/